Concepts (74)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
Disease Susceptibility | 1 | 2020 | 4002 | 0.32 | Why? |
Disease Models, Animal | 3 | 2021 | 10998 | 0.31 | Why? |
Cricetinae | 3 | 2021 | 3344 | 0.27 | Why? |
Distemper Virus, Canine | 1 | 2019 | 40 | 0.20 | Why? |
Lions | 1 | 2019 | 41 | 0.20 | Why? |
Turbinates | 1 | 2020 | 205 | 0.19 | Why? |
Mesocricetus | 2 | 2021 | 1847 | 0.19 | Why? |
Encephalitis Viruses, Tick-Borne | 1 | 2019 | 100 | 0.18 | Why? |
Immunologic Tests | 1 | 2021 | 445 | 0.18 | Why? |
Primates | 1 | 2021 | 584 | 0.17 | Why? |
Rectum | 1 | 2021 | 495 | 0.17 | Why? |
Animal Diseases | 1 | 2019 | 182 | 0.17 | Why? |
Viral Plaque Assay | 1 | 2019 | 381 | 0.17 | Why? |
Spleen | 1 | 2020 | 877 | 0.15 | Why? |
Nasal Cavity | 1 | 2021 | 909 | 0.15 | Why? |
Weight Loss | 1 | 2021 | 826 | 0.15 | Why? |
Trachea | 1 | 2020 | 894 | 0.14 | Why? |
HIV Antibodies | 1 | 2021 | 776 | 0.14 | Why? |
Fomites | 1 | 2021 | 709 | 0.14 | Why? |
Pharynx | 1 | 2021 | 1544 | 0.13 | Why? |
Immunoglobulin G | 3 | 2021 | 21571 | 0.12 | Why? |
Enzyme-Linked Immunosorbent Assay | 3 | 2021 | 7868 | 0.11 | Why? |
Viral Load | 2 | 2021 | 15850 | 0.10 | Why? |
Genome, Viral | 3 | 2020 | 13157 | 0.10 | Why? |
Mice, Inbred BALB C | 1 | 2020 | 5814 | 0.10 | Why? |
Mice, Inbred C57BL | 1 | 2020 | 5542 | 0.10 | Why? |
Animals | 8 | 2021 | 78931 | 0.09 | Why? |
Chiroptera | 2 | 2020 | 3530 | 0.09 | Why? |
Kidney | 1 | 2020 | 3648 | 0.07 | Why? |
Neutralization Tests | 1 | 2019 | 6698 | 0.07 | Why? |
Immunity, Humoral | 1 | 2020 | 4849 | 0.07 | Why? |
Immunogenicity, Vaccine | 1 | 2021 | 4624 | 0.07 | Why? |
Aerosols | 1 | 2021 | 5393 | 0.07 | Why? |
RNA, Viral | 2 | 2021 | 32276 | 0.06 | Why? |
Antibodies, Viral | 5 | 2021 | 51949 | 0.06 | Why? |
India | 4 | 2020 | 11875 | 0.06 | Why? |
Lung | 2 | 2021 | 31049 | 0.06 | Why? |
Betacoronavirus | 3 | 2020 | 204454 | 0.06 | Why? |
Coronavirus | 2 | 2021 | 18339 | 0.05 | Why? |
United Kingdom | 1 | 2021 | 18046 | 0.05 | Why? |
Macaca mulatta | 2 | 2021 | 3716 | 0.05 | Why? |
Mice | 1 | 2020 | 21357 | 0.05 | Why? |
Coronavirus Infections | 4 | 2021 | 253789 | 0.05 | Why? |
Pneumonia, Viral | 3 | 2020 | 243684 | 0.04 | Why? |
SARS Virus | 1 | 2020 | 13021 | 0.04 | Why? |
Genes, Viral | 1 | 2019 | 1428 | 0.03 | Why? |
Sequence Alignment | 1 | 2020 | 2109 | 0.03 | Why? |
Immunohistochemistry | 1 | 2021 | 2275 | 0.03 | Why? |
Hot Temperature | 1 | 2021 | 1299 | 0.03 | Why? |
Phylogeny | 2 | 2020 | 13341 | 0.03 | Why? |
Cell Line, Tumor | 1 | 2019 | 3608 | 0.03 | Why? |
Swine | 1 | 2019 | 3352 | 0.03 | Why? |
Real-Time Polymerase Chain Reaction | 2 | 2020 | 11367 | 0.03 | Why? |
Reverse Transcriptase Polymerase Chain Reaction | 2 | 2020 | 13720 | 0.02 | Why? |
Antibodies, Neutralizing | 3 | 2021 | 25288 | 0.02 | Why? |
Lymphocytes | 1 | 2021 | 3056 | 0.02 | Why? |
High-Throughput Nucleotide Sequencing | 1 | 2020 | 3633 | 0.02 | Why? |
ROC Curve | 1 | 2020 | 6024 | 0.02 | Why? |
Iran | 1 | 2020 | 5467 | 0.02 | Why? |
Predictive Value of Tests | 1 | 2020 | 9537 | 0.02 | Why? |
Seroepidemiologic Studies | 1 | 2020 | 10017 | 0.02 | Why? |
Male | 2 | 2021 | 367725 | 0.02 | Why? |
Cell Line | 1 | 2019 | 12040 | 0.02 | Why? |
Reproducibility of Results | 1 | 2020 | 11304 | 0.02 | Why? |
Vero Cells | 1 | 2019 | 14117 | 0.01 | Why? |
Travel | 1 | 2020 | 7220 | 0.01 | Why? |
Pneumonia | 1 | 2021 | 5652 | 0.01 | Why? |
Pandemics | 3 | 2020 | 389249 | 0.01 | Why? |
Prevalence | 1 | 2020 | 25773 | 0.01 | Why? |
Italy | 1 | 2020 | 38444 | 0.01 | Why? |
Clinical Laboratory Techniques | 1 | 2020 | 23402 | 0.01 | Why? |
China | 1 | 2020 | 50654 | 0.01 | Why? |
Humans | 4 | 2021 | 930598 | 0.01 | Why? |
Female | 1 | 2021 | 380317 | 0.00 | Why? |